Topics:

Major Depressive Disorder

Major Depressive Disorder

Patients with severe depression are more likely to have symptom remission with a combination of cognitive therapy and antidepressant medication than those with less severe or more chronic illness.

In what psychiatric disorder, if any, has wake therapy been useful to alleviate symptoms? Take the quiz and learn more.

Standardized, quantifiable outcome measures exist for most major psychiatric disorders, yet they are rarely used in routine clinical practice. This article identifies the rationale for using psychiatric scales.

What to do once treatment-resistant depression is established based on risk factors and exclusion of other conditions? Insights here—and a treatment algorithm.

The discovery that a single IV infusion of low-dose (subanesthetic) ketamine exerts rapid antidepressant effects constitutes an expansion in our understanding of the neurobiology of depression and provides new avenues for drug development.

Genius and madness: does one phenomenon cause the other—or do both share a common underlying factor or mechanism? How are geniuses able to accomplish “creative fits”? The author explores both questions.

How can we get even better at customizing treatment for our patients and thereby achieve improved outcomes? How do we avoid becoming relegated to mere brokers of psychopharmacologic commodities? A few thoughts in this brief communication.

Pages

Subscribe to Major Depressive Disorder on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.